Solomon Edward I, Wong Shaun D, Liu Lei V, Decker Andrea, Chow Marina S
Department of Chemistry, Stanford University, CA 94305, United States.
Curr Opin Chem Biol. 2009 Feb;13(1):99-113. doi: 10.1016/j.cbpa.2009.02.011. Epub 2009 Mar 9.
Fe(III)OOH and Fe(IV)O intermediates have now been documented in a number of nonheme iron active sites. In this Current Opinion we use spectroscopy combined with electronic structure calculations to define the frontier molecular orbitals (FMOs) of these species and their contributions to reactivity. For the low-spin Fe(III)OOH species in activated bleomycin we show that the reactivity of this nonheme iron intermediate is very different from that of the analogous Compound 0 of cytochrome P450. For Fe(IV)O S=1 model species we experimentally define the electronic structure and its contribution to reactivity, and computationally evaluate how this would change for the Fe(IV)O S=2 intermediates found in nonheme iron enzymes.
现已在许多非血红素铁活性位点中发现了Fe(III)OOH和Fe(IV)O中间体。在本《当前观点》中,我们结合光谱学和电子结构计算来定义这些物种的前沿分子轨道(FMO)及其对反应活性的贡献。对于活化博来霉素中的低自旋Fe(III)OOH物种,我们表明这种非血红素铁中间体的反应活性与细胞色素P450的类似化合物0的反应活性非常不同。对于Fe(IV)O S=1模型物种,我们通过实验定义了其电子结构及其对反应活性的贡献,并通过计算评估了在非血红素铁酶中发现的Fe(IV)O S=2中间体的情况会如何变化。